Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
Holding BRNS?
Track your performance easily

Barinthus Biotherapeutics (BRNS) Balance Sheet

84 Followers

Barinthus Biotherapeutics Balance Sheet

Barinthus Biotherapeutics's total assets for Q3 2024 were $188.69M, an increase of 1.04% from the previous quarter. BRNS total liabilities were $29.23M for the fiscal quarter, a -2.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 214.51M$ 270.20M$ 280.71M$ 50.67M$ 19.04M
Total Liabilities
$ 27.51M$ 27.00M$ 28.15M$ 87.58M$ 41.12M
Total Equity Gross Minority
$ 187.00M$ 243.20M$ 252.56M$ -36.91M$ -22.08M
Total Capitalization
$ 197.97M$ 251.24M$ 258.67M$ 7.40M$ -22.45M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.66M$ 1.78M
Currency in USD

Barinthus Biotherapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis